Last reviewed · How we verify
Matching placebo to glimepiride — Competitive Intelligence Brief
marketed
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Matching placebo to glimepiride (Matching placebo to glimepiride) — Merck Sharp & Dohme LLC. This is a placebo formulation designed to match the appearance and characteristics of glimepiride for use in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Matching placebo to glimepiride TARGET | Matching placebo to glimepiride | Merck Sharp & Dohme LLC | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Matching placebo to glimepiride CI watch — RSS
- Matching placebo to glimepiride CI watch — Atom
- Matching placebo to glimepiride CI watch — JSON
- Matching placebo to glimepiride alone — RSS
Cite this brief
Drug Landscape (2026). Matching placebo to glimepiride — Competitive Intelligence Brief. https://druglandscape.com/ci/matching-placebo-to-glimepiride. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab